IGFBP7 and acute kidney injury: The effectiveness of the KDIGO AKI recommendations for prevention of AKI in high-risk patients (defined as [TIMP2]·[IGFBP7] positive) of all surgical disciplines is currently being investigated in the international, multicenter BigpAK-2 randomized controlled trial [35, 44].